Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2005
06/14/2005US6906170 Anti-inflammatory peptides derived from IL-2 and analogues thereof
06/14/2005US6906169 Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
06/14/2005US6906037 Therapeutic peptide-based constructs
06/14/2005US6906036 Anti-aging and wound healing compounds
06/14/2005US6906035 Useful for inhibiting microbial infection or growth, as well reducing the effects of endotoxemia
06/14/2005US6906034 Insulin like growth factor binding protein complex for use as wound healing agent in animals and humans
06/14/2005US6906033 Isolated DNA encoding amino acid sequences, serine protease inhibitor, host cell transformed with a DNA molecule, Kunitz type Inhibitor, blood coagulation factors
06/14/2005US6906029 Insulin-like growth factor binding protein (IGFBP-5)
06/14/2005US6905877 Compositions and methods for altering amino acid content of proteins
06/14/2005US6905873 Recombinant p53 adenovirus methods and compositions
06/14/2005US6905868 Cleaning compounds; animal feeds
06/14/2005US6905853 Phenol oxidizing enzyme variants
06/14/2005US6905846 Nucleic acids encoding factor X deletion mutants and analogues thereof
06/14/2005US6905845 Isolated nucleic acids; allergies sensitivity
06/14/2005US6905844 Human cervical cancer 2 protooncogene and protein encoded therein
06/14/2005US6905842 Modulation signal transduction; isolated nucleic acids; genetic engineering
06/14/2005US6905836 Methods for inhibiting the activation of nuclear factor kappaB (NF- kappa B)
06/14/2005US6905832 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP)
06/14/2005US6905820 Polyamide nucleic acid derivatives, and agents and processes for preparing them
06/14/2005US6905704 Animal extracts; hypotensive agent; storage stability
06/14/2005US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases
06/14/2005US6905687 Fusion proteins; immunogens; solid phase synthesis; kits
06/14/2005US6905686 Active immunization for treatment of alzheimer's disease
06/14/2005US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents
06/14/2005US6905684 Preventives and remedies for diffuse lung diseases
06/14/2005US6905682 Hybrid nucleic acids, ant antibodies thereof; insecticide
06/14/2005US6905681 Methods for selectively stimulating proliferation of T cells
06/14/2005US6905680 Induction of lymphocytes; obtain cells, activate cells, incubate with activator, monitor lymphocyte proliferation
06/14/2005US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents
06/14/2005US6905670 Exposing eukaryotic organisms to a single fungal pathogen in the presence of at least one candidate compound; identifying a compound that inhibits fungal pathogen in each of eukaryotic organisms
06/14/2005CA2400318C Botulinum toxin pharmaceutical compositions
06/14/2005CA2284100C New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof
06/14/2005CA2264585C Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
06/14/2005CA2164088C Plasmids suitable for gene therapy
06/14/2005CA2106718C Methods for the production of hybrid seed
06/14/2005CA2100423C Parathyroid hormone analogs having parathyroid hormone-like activity
06/09/2005WO2005052590A1 High-throughput screening method for integrin antagonist and new peptide screened therefrom
06/09/2005WO2005052586A2 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3)
06/09/2005WO2005052191A2 Compositions and methods for the diagnosis and treatment of tumor
06/09/2005WO2005052172A1 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (lcmv)
06/09/2005WO2005052171A2 Retroviral and lentiviral vectors
06/09/2005WO2005052169A2 Plant disease resistance and sar regulator protein
06/09/2005WO2005052166A1 Recombinant peptide vector comprising the gene for treatment for autoimmune diseases.
06/09/2005WO2005052159A1 Latent phase viral interleukin-10-(vii-10) and uses thereof
06/09/2005WO2005052157A1 Il-23 and its receptor; related reagents and methods
06/09/2005WO2005052150A1 Method of controlling transcription of insulin gene
06/09/2005WO2005052141A1 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by wnt factors
06/09/2005WO2005052130A2 Nrbps as modifiers of the rac pathway and methods of use
06/09/2005WO2005052129A2 Diptheria toxin variant
06/09/2005WO2005052123A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof
06/09/2005WO2005052122A2 METHODS FOR CONTROLLING PATHOLOGICAL ANGIOGENESIS BY INHIBITION OF α6β4 INTEGRIN
06/09/2005WO2005052007A1 Recombinant anti-cd64-immunotoxins
06/09/2005WO2005052006A2 Mutated anti-cd22 antibodies and immunoconjugates
06/09/2005WO2005052003A2 Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis
06/09/2005WO2005052001A2 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
06/09/2005WO2005052000A2 Anti-il-20 antibodies and binding partners and methods of using in inflammation
06/09/2005WO2005051999A2 Substance binding human igg fc receptor iib
06/09/2005WO2005051996A2 Protein from horn fly saliva that disrupts hemostasis
06/09/2005WO2005051995A2 Novel advanced glycosylation end product-specific receptor-like protein and nucleic acids encoding same
06/09/2005WO2005051994A2 Ztnf11, a tumor necrosis factor
06/09/2005WO2005051993A1 Novel muscle growth regulator
06/09/2005WO2005051992A1 Use of neublasmin as a maker for testis cancer
06/09/2005WO2005051990A2 Polynucleotides overexpressed in breast cancer cells, compositions and methods for the therapy and diagnosis of breast cancer
06/09/2005WO2005051989A2 Novel agents for the prevention of leishmaniosis
06/09/2005WO2005051988A2 Compositions and methods for the treatment of systemic lupus erythematosis
06/09/2005WO2005051987A1 Purification method for a recombinant glucose binding protein
06/09/2005WO2005051986A1 Polyvalent allergy vaccine
06/09/2005WO2005051985A2 Methods for purifying pertussis toxin and peptides useful therefor
06/09/2005WO2005051984A2 Methods for producing olfactory gpcrs
06/09/2005WO2005051983A2 Oligomeric complexe formation of recombinant multi subunit chimeric polypeptides
06/09/2005WO2005051982A1 Glycopeptides and temperature-responsive micelles
06/09/2005WO2005051977A2 Conditional allele system
06/09/2005WO2005051975A2 Methods for obtaining molecules with reduced immunogenicity
06/09/2005WO2005051973A2 Peptides derived from natural cytotoxicity receptors and methods of use thereof
06/09/2005WO2005051971A1 Reduction of dermal scarring
06/09/2005WO2005051799A2 Peptide increasing fusiogenic capacity of a gamete
06/09/2005WO2005051662A2 Methods for detecting l-ficolin dependent activation of the lectin pathway of complement and kits therefor
06/09/2005WO2005051432A1 Therapeutic regimen for treating cancer
06/09/2005WO2005051425A1 Procaspase 1 activation inhibitor
06/09/2005WO2005051420A1 Novel immunogenic peptide and novel epitopes and the use thereof for producing active pharmaceutical compositions against a hepatitis c virus
06/09/2005WO2005051327A2 Glycopegylated erythropoietin
06/09/2005WO2005051313A2 Methods and reagents for treating, preventing and diagnosing bunyavirus infection
06/09/2005WO2005041758A9 Novel cell-based assays employing voltage and calcium dyes
06/09/2005WO2005035773A8 Modified cea /b7 vector
06/09/2005WO2005030970A3 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances
06/09/2005WO2005030939A3 Method and composition for regulating expansion of stem cells
06/09/2005WO2005030136A3 Tumor vaccine
06/09/2005WO2005028630A3 Engineered zinc finger proteins for regulation of gene expression
06/09/2005WO2005028499A3 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom
06/09/2005WO2005026194A3 Granulysin peptides and methods of use thereof
06/09/2005WO2005023854A3 Modified 6-phosphofructo-1-kinase of the fungus aspergillus niger
06/09/2005WO2005023096A3 Methods and compositions for ultrasound imaging of apoptosis
06/09/2005WO2005021765A3 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins
06/09/2005WO2005021592A3 Enhancing the circulating half-life of interleukin-2 proteins
06/09/2005WO2005017198A3 Surface display expression system
06/09/2005WO2005015206A3 Secreted polypeptide species associated with cardiovascular disorders
06/09/2005WO2005014638A3 Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family
06/09/2005WO2005014039A3 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative diseases
06/09/2005WO2005011722A3 Use of vegf-c or vegf-d in reconstructive surgery
06/09/2005WO2005010032A3 Replikin peptides and uses thereof
1 ... 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 ... 2916